References

Anderson, R.G.W., 1998. The caveolae membrane system. Annu. Rev. Biochem., 67: 199-225.
PubMed  |  Direct Link  |  

Blouin, C.M., S.L. Lay, F. Lasnier, I. Dugail and E. Hajduch, 2008. Regulated association of caveolins to lipid droplets during differentiation of 3t3-l1 adipocytes. Biochem. Biophys. Res. Commun., 376: 331-335.
CrossRef  |  

Capozza, F., A.W. Cohen, M.W.C. Cheung, F. Sotgia and W. Schubert et al., 2005. Muscle-specific interaction of caveolin isoforms: Differential complex formation between caveolins in fibroblastic vs. Muscle cells. Am. J. Physiol. Cell Physiol., 288: C677-C691.
Direct Link  |  

Cohen, A.W., R. Hnasko, W. Schubert and M.P. Lisanti, 2004. Role of caveolae and caveolins in health and disease. Physiol. Rev., 84: 1341-1379.
Direct Link  |  

Cohen, A.W., T.P. Combs, P.E. Scherer and M.P. Lisanti, 2003. Role of caveolin and caveolae in insulin signaling and diabetes. Am. J. Physiol. Endocrinol. Metab., 285: E1151-E1160.
Direct Link  |  

Fujimoto, T., H. Hagiwara, T. Aoki, H. Kogo and R. Nomura, 1998. Review caveolae: From a morphological point of view. J. Electron Microsc., 47: 451-460.
Direct Link  |  

Fujimoto, T., H. Kogo, K. Ishiguro, K. Tauchi and R. Nomura, 2001. Caveolin-2 is targeted to lipid droplets, a new membrane domain in the cell. J. Cell Biol., 152: 1079-1085.
Direct Link  |  

Galbiati, F., D. Volonte, J.A. Engelman, P.E. Scharer and M.P. Lisanti, 1999. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating c2c12 myoblasts. J. Biol. Chem., 274: 30315-30321.
Direct Link  |  

Galbiati, F., J.A. Engelman, D. Volonte, X.L. Zhang and C. Minetti et al., 2001. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities. J. Biol. Chem., 276: 21425-21433.
PubMed  |  

Gargalovic, P. and L. Dory, 2003. Caveolins and macrophage lipid metabolism. J. Lipid Res., 44: 11-21.

Gonzalez-Munoz, E., C. Lopez-Iglesias, M. Calvo, M. Palacin, A. Zorzano and M. Camps, 2009. Caveolin-1 loss of function accelerates glucose transporter 4 and insulin receptor degradation in 3t3-l1 adipocytes. Endocrinology, 150: 3493-3502.
PubMed  |  

Ikonen, E., S. Heino and S. Lusa, 2004. Caveolins and membrane cholesterol. Biochem. Soc. Trans., 32: 121-123.
PubMed  |  

Krajewska, W.M. and I. Maslowska, 2004. Caveolins: Structure and function in signal transduction. Cell. Mol. Biol. Lett., 9: 195-220.
PubMed  |  

Nixon, S.J., J. Wegner, C. Ferguson, P.F. Mery and J.F. Hancock et al., 2005. Zebrafish as a model for caveolin-associated muscle disease, caveolin-3 is required for myofibril organization and muscle cell patterning. Hum. Mol. Genet., 14: 1727-1743.
PubMed  |  

Okamoto, T., A. Schlegel, P.E. Scherer and M.P. Lisanti, 1998. Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J. Biol. Chem., 273: 5419-5422.
PubMed  |  

Parton, R.G., M. Way, N. Zorzi and E. Stang, 1997. Caveolin-3 associates with developing t-tubules during muscle differentiation. J. Cell Biol., 136: 137-154.
PubMed  |  

Pol, A., S. Martin, M.A. Fernandez, C. Ferguson, A. Carozzi, R. Luetterforst, C. Enrich and R.G. Parton, 2004. Dynamic and regulated association of caveolin with lipid bodies: Modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell, 15: 99-110.
Direct Link  |  

Quest, A.F.G., L. Leyton and M. Pcrraga, 2004. Caveolins, caveolae, and lipid rafts in cellular transport, signaling, and disease. Biochem. Cell Biol., 82: 129-144.
PubMed  |  

Razani, B., T.P. Combs, X.B. Wang, P.G. Frank and D.S. Park et al., 2002. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. J. Biol. Chem., 277: 8635-8647.
PubMed  |  

Scherer, P.E., T. Okamoto, M. Chun, I. Nishimoto, H.F. Lodish and M.P. Lisanti, 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci., 93: 131-135.
Direct Link  |  

Singh, R.D., V. Puri, J.T. Valiyaveettil, D.L. Marks, R. Bittman and R.E. Pagano, 2003. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell, 14: 3254-3265.
Direct Link  |  

Song, K.S., P.E. Scherer, Z.L. Tang, T. Okamoto and S. Li et al., 1996. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J. Biol. Chem., 271: 15160-15165.
PubMed  |  Direct Link  |  

Tang, Z.L., P.E. Scherer, T. Okamoto, K. Song and C. Chu et al., 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem., 271: 2255-2261.
Direct Link  |  

Vandesompele, J., K. De Preter, F. Pattyn, B. Poppe, N. van Roy, A. De Paepe and F. Speleman, 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol., 3: 1-11.
CrossRef  |  Direct Link  |  

Wilson, L.B., 1905. A method for the rapid preparation of fresh tissues for the microscope. J. Am. Med. Assoc., 45: 1737-1737.

Zhu, Z., Y. Li, D. Mo, K. Li and S. Zhao, 2006. Molecular characterization and expression analysis of the porcine caveolin-3 gene. Biochem. Biophys. Res. Commun., 346: 7-13.